30 ft Robot In Wimpole Street To Power Pioneer e-Prescription Pharmacy Expansion

Pharmacierge, the leader in private e-prescription app and delivery services announces its forthcoming expansion within the heart of London’s healthcare district.  The expansion includes an extensive new 5,500 sqft dispensary equipped with a 30ft dispensing robot, both the largest of their kind in the prestigious Harley Street Medical Area (HSMA).  Pharmacierge is itself backed by 80 leading private GPs and Consultants spanning all medical specialties.

Acquiring the additional lease in Wimpole Street marks a significant milestone on Pharmacierge’s mission to becoming the pharmacy partner of choice to all leading private practices and private hospitals. With this move, the brand’s operations parallel to Harley Street will grow to 8,000 sqft, or tenfold the size of its original location in 2015.

Cutting-Edge Software And Pharmacy Design

In its relentless pursuit of innovation, Pharmacierge has engaged a world-renowned pharmacy designer to reimagine its latest incarnation.  The ambitious transformation of two 18th-century Georgian properties into one streamlined clinical space is already underway.  The project aspires to revolutionising the private pharmacy pathway, marrying cutting-edge technology and robotics with traditional pharmacy values and integrity.  In addition to generic and branded medicines, the plans also include dedicated sub-divided areas for controlled, refrigerated and biological medications.

Robotic Dispensing and AI-Driven Stock Management

A 30 ft multi-arm dispensing robot, unprecedented in central London, will soon occupy one wing of the new premises, with medication chutes spiralling down through the floor to the spacious modern dispensary beneath.  This robotic automation is projected to improve overall efficiency and enhance rapid availability of the broadest possible pharmacy formulary.  Pharmacierge already caters to a network of over 4,500 GP and Consultant users.

Scalable Partnerships with Private Practices and Hospitals

Pharmacierge is already the preferred pharmacy partner to many of the leading UK and US hospital groups in London.  With these robotic automation and scalability gains, it plans to bring the time and cost-saving benefits of ‘ePrescribing-as-a-service’ to further private practitioners, hospitals and private patient units (PPU) throughout the UK.  Over 90% of clinicians surveyed believe that Pharmacierge ePrescribing saves their practice 5-15 mins per prescription, while patients are spared the impact and inconvenience of multiple car journeys and pharmacy visits.  Institutional benefits include centralised administration, real-time tracking and simplified pre-op medication pathways.

Pharmacy and Medical Heritage

Pharmacierge’s co-founders share well over a century of combined medical and pharmacy heritage in the Harley Street area, having previously co-founded The Doctor’s Laboratory (TDL), also on Wimpole Street, and other pharmacies within the Marylebone and Mayfair estates.

Commenting on the transaction, Edward Ungar, CEO said, “While our mPrescribe® technology now equally serves clinicians and patients outside of London, we felt very strongly that only a local investment would remain faithful to our brand values, our roots and the private medical community who have supported us through thick and thin.”

Julian Best, Executive Property Director of The Howard de Walden Estate comments: “We are delighted Pharmacierge has chosen to expand their operation in the Harley Street Medical Area, bolstering the technology led patient experience for the delivery of prescriptions and ensuring the area continues to offer the highest level of patient service.”

 

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”
Exit mobile version